Figure 1.
Figure 1. Cumulative risk of clinically relevant bleeding in cancer-associated thrombosis patients who received low-molecular weight heparin

Cumulative risk of clinically relevant bleeding in cancer-associated thrombosis patients who received low-molecular weight heparin

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal